Genomcore and DIPCAN transform metastatic cancer treatment in Spain

Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2,000 participants.

Share this article

Leer en Español

Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2,000 participants.

Related articles

Genomcore team at the European Human Genetics Conference 2026

Genomcore at ESHG 2026: from the lab to the clinical decision

María Díez, QARA Lead at Genomcore, presenting the Made of Genes and Genomcore solution at the EU AI Sandbox closing ceremony

Genomcore passes the first EU AI Sandbox through its spin-off, Made of Genes

David G. Pisano, Clinical Bioinformatics Director at Genomcore, participating in the roundtable on management and analysis models in the NHS during the 1st Clinical Bioinformatics Conference organized by SEBiBC at ISCIII, Madrid

Genomcore at the 1st SEBiBC Clinical Bioinformatics Conference: clinical bioinformatics that reaches the patient